Black Diamond Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations, expanding the addressable patient population by offering one solution for many mutations. Our mission: defeat cancer resistance and provide people living with cancer the opportunity to experience longer, healthier and more active lives. We are advancing silevertinib, a potent, brain penetrant fourth-generation EGFR inhibitor for patients with non-small cell lung cancer (NSCLC) and glioblastoma (GBM).